Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model

Affiliations

• ¹ Department of Hematology-Oncology, Azienda Ospedaliera Pugliese-Ciaccio, Catanzaro, Italy.
• ² Biostatistic Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
• ³ Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
• ⁴ Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
• ⁵ Institute of Hematology-Centro di Ricerca Emato-Oncologica (CREO), Department of Medicine, University of Perugia, Perugia, Italy.
• ⁶ Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda Milano, Milan, Italy.
• ⁷ Division of Hematology, Ferrarotto Hospital, Catania, Italy.
• ⁸ Hematology Unit, Careggi Hospital, Florence, Italy.
• ⁹ Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
• ¹⁰ Institute of Haematology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
• ¹¹ Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
• ¹² Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco AO Brotzu, Cagliari, Italy.
• ¹³ Hematology Unit, Hematology and Oncology Department, Cosenza, Italy.
• ¹⁴ Hematology, Department of Medical Sciences, St. Anna University Hospital, Ferrara, Italy.
• ¹⁵ Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, University of Bari, Bari, Italy.
• ¹⁶ Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy.
• ¹⁷ Department Hematology, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
• ¹⁸ Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.